Niagen Bioscience, Inc. (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the broadening of its ...

Niagen Bioscience, Inc. (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today confirmed it has changed its ...

Cystic fibrosis (CF) is a life-threatening autosomal recessive disease affecting over 160,000 people worldwide. CF is caused by loss-of-function mutations in the CF transmembrane conductance regulator ...

ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on the science ...

Supplementing NAD+ precursors can help to increase production of the molecule in the body. Longevity-seekers, especially the ...

Nicotinamide adenine dinucleotide (NAD+) is a natural compound in your body. It plays a role in several important processes, ...

H.C. Wainwright analyst Patrick Trucchio reiterates a Buy rating and $80 price target on Beam Therapeutics (BEAM) shares after the company ...

The authors have demonstrated the use of adenine base editors delivered via adeno-associated viruses to introduce edits in the mitochondrial genome. The manuscript describes the methodology well, and ...

However, the mechanism of action of JT against renal interstitial fibrosis remain unknown. Objective: This study aimed to explore the potential effects and mechanisms of JT on adenine - diet - induced ...

产品名称：[特惠]腺苷,99%生物技术级. 中文别名： 阿糖腺苷;9-beta-D-阿拉伯呋喃糖基腺嘌呤;9-Β-D-阿拉伯呋喃糖基腺嘌呤;9-Β-D-阿拉伯呋喃糖腺嘌呤；9-Β-D-ARABINOFURANOSYLADENINE MONOHYDRATE;腺嘌呤阿拉伯糖苷；ADENINE ARABINOSIDE;阿糖腺嘌吟;腺嘌吟阿拉伯糖苷;腺苷;腺嘌呤核 ...

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans. Now, researchers at Harvard University have designed a new class ...